“IMP-1 Inhibits Renal Cell Carcinoma 786-O Cell Growth by Targeting EphrinB2 Signaling Pathway”.
Brazilian Journal of Pharmaceutical Sciences
, vol. 59, June 2023, p. e22102,
https://doi.org/10.1590/s2175-97902023e22102
.